About Cytogenetics Media
The cytogenetics media is used in culturing human peripheral blood cells, bone, marrow, T-cell lymphocytes, and other human specimens for cytogenetic analysis. It is used basically for the study of chromosomes, for example, the analysis is very important for the diagnosis, classification, prognosis, and management of acute myeloid leukemia (AML) which can be only done with the help of cytogenetics media. This test helps doctors and researchers to help identify potential diseases like leukemia and provide proper treatment guidance. Cytogenetic testing is generally done through the bone marrow of AML patients and helps in categorizing the level of leukemia and it also assists in treatment response and overall prognosis.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Competition among existing players is due to the Cytogenetics Media market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for Cytogenetics Media Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Thermo Fisher Scientific Inc. (United States), FUJIFILM Irvine Scientific (United States), Biological Industries (United States), Precipio, Inc. (United States), TRINOVA BIOCHEM GmbH (Germany), Zotal Biological and Instrumentation (Israel), Sanbio B.V. (Netherlands), Yanyi Bio (China) and Euroclone (Italy) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are PerkinElmer (United States) and Others.
Segmentation Overview
AMA Research has segmented the market of Global Cytogenetics Media market by Type (Basal Medium, Complete Medium, Chromosome Medium, Bone Marrow Medium and Others), Application (Cytogenetics Laboratories, Medical Center, Scientific Research and Others) and Region.
On the basis of geography, the market of Cytogenetics Media has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Techniques, the sub-segment i.e. Karyotyping or Routine Cytogenetic Analysis will boost the Cytogenetics Media market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Product Size, the sub-segment i.e. 450mL will boost the Cytogenetics Media market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technological Advancements in Cytogenetics Analysis and Continuous Research and Development for Cytogenetics Media
Market Growth Drivers:
The growing need for the study of chromosomes for the proper diagnosis and treatment of the genetic issues in the body. The cytogenetics media optimizes the performance of the cell, increase consistency during the analysis. The genetically evolved problems need treatment where cytogenetics analysis helps.
Challenges:
High Cost Involved with Cytogenetics Media
Restraints:
The Time-Consuming Process Associated with the Research and Production of Cytogenetics Media
Opportunities:
Growing Research and Development Infrastructure
Market Leaders and their expansionary development strategies
In December 2019, Sartorius, a leading international partner of life science research and the biopharmaceutical industry, signed an agreement to acquire a majority stake in the Israeli cell culture media developer and manufacturer Biological Industries. For approximately €45 million in cash, Sartorius is acquiring just over 50% of the shares of the company from its owners, Kibbutz Beit Haemek and private equity fund Fortissimo Capital. An option to acquire a further 20% of the shares within three years was also agreed. The transaction is subject to customary closing conditions and expected to be finalized by mid-December.
In July 2019, Fujifilm Irvine Scientific Inc. which is a global leader in the innovation, development, and manufacture of cell culture media, announced its plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan. Fujifilm’s investment in this project demonstrates its commitment to accelerate development in bioproduction, and cell and gene therapy markets.
"According to the Medical laboratories – Requirements for quality and competence legislation standards the general, routine cytogenetic analysis should consist of a minimum of 5 banded cells analyzed, 10 cells counted (in addition to the already counted cells). In cases where clinically relevant mosaicism is suspected, counting, analysis or scoring of at least 30 cells is recommended to exclude mosaicism of 10% at the 0.95 confidence level. For cancer cytogenetics, if no chromosomal abnormality is found in the first five cells analyzed, then a further five cells are to be fully analyzed and an additional 10 cells are to be counted."
Key Target Audience
Cytogenetics Media Manufacturer, Cytogenetics Media International Traders, Cytogenetics Media Distributors and Suppliers, Research and Development Institutes, Regulatory Bodies, Industry Associations, Potential Investors and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.